(Updates with the company's latest stock move in the headline and the first paragraph.)
Medpace (MEDP) shares surged more than 15.5% in Thursday trading after the company reported stronger-than-expected Q2 earnings and revenue late Wednesday.
The company posted Q2 earnings of $4.25 per diluted share, up from $3.10 a year earlier.
Analysts polled by FactSet expected $3.98.
Revenue for the quarter ended June 30 was $707.3 million, up from $603.3 million a year ago.
Analysts expected $689.5 million.
For full-year 2026, the company expects EPS of $17.25 to $17.95 per share on revenue of $2.81 billion to $2.89 billion.
Analysts expect $16.97 on revenue of $2.77 billion.
Price: $610.09, Change: $+81.97, Percent Change: +15.52%